330
Views
22
CrossRef citations to date
0
Altmetric
Research Article

The small-molecule inhibitor selectivity between IKKα and IKKβ kinases in NF-κB signaling pathway

, , , , , & show all
Pages 307-318 | Received 09 Sep 2014, Accepted 22 Oct 2014, Published online: 11 Nov 2014

References

  • Lawrence T. The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb Perspect Biol 2009;1:a001651
  • Häcker H, Karin M. Regulation and function of IKK and IKK-related kinases. Sci STKE 2006;2006:re13
  • Lee DF, Hung MC. Advances in targeting IKK and IKK-related kinases for cancer therapy. Clin Cancer Res 2008;14:5656–62
  • Israël A. The IKK complex, a central regulator of NF-kappaB activation. Cold Spring Harb Perspect Biol 2010;2:a000158
  • Adli M, Merkhofer E, Cogswell P, et al. IKKα and IKKβ Each function to regulate NF-κB activation in the TNF-induced/canonical pathway. PLoS One 2010;5:e9428
  • Chou KC. Some remarks on predicting multi-label attributes in molecular biosystems. Mol BioSyst 2013;9:1092–100
  • Li XB, Wang SQ, Xu WR, et al. Novel inhibitor design for hemagglutinin against H1N1 influenza virus by core hopping method. PLoS One 2011;6:e28111
  • Chou KC. Pseudo amino acid composition and its applications in bioinformatics, proteomics and system biology. Curr Proteomics 2009;6:262–74
  • Zhou P, Wang C, Ren Y, et al. Computational peptidology: a new and promising approach to therapeutic peptide design. Curr Med Chem 2013;20:1985–96
  • Rüegg UT, Burgess GM. Staurosporine, K-252 and UCN-01: potent but nonspecific inhibitors of protein kinases. Trends Pharm Sci 1989;10:218–20
  • Berman HM, Westbrook J, Feng Z, et al. The protein data bank. Nucleic Acids Res 2000;28:235–42
  • Word JM, Lovell SC, Richardson JS, et al. Asparagine and glutamine: using hydrogen atom contacts in the choice of side-chain amide orientation. J Mol Biol 1999;285:1735–47
  • Xiang Z. Advances in homology protein structure modeling. Curr Protein Pept Sci 2006;7:217–27
  • UniProt C. Activities at the universal protein resource (UniProt). Nucleic Acids Res 2014;42:D191–8
  • Altschul S, Gish W, Miller W, et al. Basic local alignment search tool. J Mol Biol 1990;215:403–10
  • Fiser A, Sali A. Modeller: generation and refinement of homology-based protein structure models. Meth Enzymol 2003;374:461–91
  • Duan Y, Wu C, Chowdhury S, et al. A point-charge force field for molecular mechanics simulations of proteins. J Comput Chem 2003;24:1999–2012
  • Du QS, Huang RB, Wang CH. Energetic analysis of the two controversial drug binding sites of the M2 proton channel in influenza A virus. J Theor Biol 2009;259:159–64
  • Du QS, Wang S, Wei DQ, et al. Molecular modelling and chemical modification for finding peptide inhibitor against SARS CoV Mpro. Anal Biochem 2005;337:262–70
  • Wang SQ, Du QS, Huang RB. Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virus. Biochem Biophys Res Comm 2009;386:432–6
  • Goodsell DS, Morris GM, Olson AJ. Automated docking of flexible ligands: applications of AutoDock. J Mol Recogn 1996;9:1–5
  • Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 2010;31:455–61
  • Zhou P, Zou J, Tian F, et al. Fluorine bonding – how does it work in protein–ligand interactions? J Chem Inf Model 2009;49:2344–55
  • Tian F, Yang L, Lv F, et al. Why OppA protein can bind sequence-independent peptides? A combination of QM/MM, PB/SA, and structure-based QSAR analyses. Amino Acids 2011;40:493–503
  • Vreven T, Byun KS, Komaromi I, et al. Combining quantum mechanics methods with molecular mechanics methods in ONIOM. J Chem Theory Comput 2006;2:815–26
  • Kollman PA, Massova I, Reyes C, et al. Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. Acc Chem Res 2000;33:889–97
  • Tian F, Lv Y, Zhou P, et al. Characterization of PDZ domain–peptide interactions using an integrated protocol of QM/MM, PB/SA, and CFEA analyses. J Comput Aided Mol Des 2011;25:947–58
  • Rocchia W, Alexov W, Honig B. Extending the applicability of the nonlinear Poisson-Boltzmann equation: multiple dielectric constants and multivalent ions. J Phys Chem B 2001;105:6507–14
  • Thompson JD, Gibson TJ, Plewniak F, et al. The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 1997;25:4876–82
  • Zhou P, Tian F, Li Z. A structure-based, quantitative structure-activity relationship approach for predicting HLA-A*0201-restricted cytotoxic T lymphocyte epitopes. Chem Biol Drug Des 2007;69:56–67
  • Tian F, Lv Y, Yang L. Structure-based prediction of protein–protein binding affinity with consideration of allosteric effect. Amino Acids 2012;43:531–43
  • Zhou P, Tian F, Li Z. Quantitative structure-property relationship studies for collision cross sections of 579 singly protonated peptides based on a novel descriptor as molecular graph fingerprint (MoGF). Anal Chim Acta 2007;597:214–22
  • Zhou P, Tian F, Lv F, et al. Comprehensive comparison of eight statistical modelling methods used in quantitative structure-retention relationship studies for liquid chromatographic retention times of peptides generated by protease digestion of the Escherichia coli proteome. J Chromatogr A 2009;1216:3107–16
  • Chou KC. Review: structural bioinformatics and its impact to biomedical science. Curr Med Chem 2004;11:2105–34
  • Wang SQ, Du QS. Study of drug resistance of chicken influenza A virus (H5N1) from homology-modeled 3D structures of neuraminidases. Biochem Biophys Res Comm 2007;354:634–40
  • Chou KC. Molecular therapeutic target for type-2 diabetes. J Proteome Res 2004;3:1284–8
  • Wang JF, Gong K, Wei DQ. Molecular dynamics studies on the interactions of PTP1B with inhibitors: from the first phosphate-binding site to the second one. Protein Eng Des Sel 2009;22:349–55
  • Chou KC. The biological functions of low-frequency phonons: 6. A possible dynamic mechanism of allosteric transition in antibody molecules. Biopolymers 1987;26:285–95
  • Volkamer A, Kuhn D, Rippmann F, et al. DoGSiteScorer: a web server for automatic binding site prediction, analysis and druggability assessment. Bioinformatics 2012;28:2074–5
  • Zhou P, Huang J, Tian F. Specific noncovalent interactions at protein–ligand interface: implications for rational drug design. Curr Med Chem 2012;19:226–38
  • Levinson NM, Boxer SG. A conserved water-mediated hydrogen bond network defines bosutinib's kinase selectivity. Nat Chem Biol 2014;10:127–32
  • Chen H, Sun T, Chen H, et al. Structural and energetic insights into the selective interactions of monoacylglycerol lipase with its natural substrate and small-molecule inhibitors. Med Chem Res 2014;23:2391–404
  • Tanaka A, Konno M, Muto S, et al. A novel NF-kB inhibitor, IMD-0354, suppresses neoplastic proliferation of human mast cells with constitutively activated c-kit receptors. Blood 2005;105:2324–31
  • Chen W, Feng PM. iRSpot-PseDNC: identify recombination spots with pseudo dinucleotide composition. Nucleic Acids Res 2013;41:e68
  • Guo SH, Deng EZ, Xu LQ, et al. iNuc-PseKNC: a sequence-based predictor for predicting nucleosome positioning in genomes with pseudo k-tuple nucleotide composition. Bioinformatics 2014;3:1522–9
  • Liu B, Xu J, Lan X, et al. iDNA-Prot|dis: identifying DNA-binding proteins by incorporating amino acid distance-pairs and reduced alphabet profile into the general pseudo amino acid composition. PLoS One 2014;9:e106691
  • Chou KC. Some remarks on protein attribute prediction and pseudo amino acid composition. J Theor Biol 2011;273:236–47

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.